All posts

VersaPay keeps “Buy” rating at Haywood after “mixed” quarter

Following the company’s second quarter results, Haywood Securities analyst Daniel Rosenberg has maintained his “Buy” rating on VersaPay (VersaPay Stock Quote, Chart, News TSXV:VPY).

On Wednesday, VersaPay reported its Q2, 2019 results. The company lost $3.45-million on revenue of $2.18-million, a topline that was up 88 per cent over the same period last year.

MasterCard deal highlights VersaPay’s second quarter

Management recounted the quarterly highlights, including a deal with MasterCard on a Virtual Card Receivables Service, what it regards as a strong quarter for ARC sales, and a high conversion of its backlog or ARC, wherein 85 per cent all sales came from the United States.

“I’m pleased to announce that VersaPay continued its strong growth for a third consecutive quarter, with total revenues increasing 88 per cent year over year to $2.18-million,” CEO Craig O’Neill said. “ARC continues to be our primary growth driver with growth of 156 per cent year over year to $1.66-million. Our recurring business (ARR) is approximately $7.50-million at the end of the quarter with ARC representing approximately 73 per cent of this figure. As a result, our gross margins were positively impacted, growing to 81 per cent this quarter, up from 75 per cent in Q2 2018.”

Better things are on the way, the analyst says

Rosenberg says this was a “mixed” quarter that he nonetheless thinks will set up a strong 2020 for VersaPay.

“VersaPay reported revenue of $2.2M in Q2CY19, an increase of 88% compared to revenue of $1.2M in Q2CY18 and slightly ahead of consensus $2.1M,” the analyst says. “VersaPay reported an Adj. EBITDA loss of $2.6M in Q2CY19, which was better than last year’s Adj. EBITDA loss of $2.8M but worse than consensus Adj. EBITDA loss of $2.2M. Revenue growth was driven by strong U.S. activity with 15 new ARC clients signed in the quarter. Product mix with ARC helped improve gross margins north of 80% but higher expenses due to timing of marketing activities negatively impacted profitability.”

In a research update to clients today, Rosenberg maintained his “Buy” rating and one-year price target of $2.30 on VersaPay, implying a return of 29 per cent at the time of publication. He categorizes the risk factor on the stock as “Very High”.

Rosenberg thinks VPY will post Adjusted EBITDA of negative $9.6-million on revenue of $9.3-million in fiscal 2019. He expects those numbers will improve to Adjusted EBITDA of negative $4.4-million on a topline of $16.5-million the following year.

VersaPay slightly cheaper than its peer group…

The analyst says the stock remains cheap when compared to its peers.

“VersaPay is currently trading at 4.7x EV/Revenue of our CY20 estimates vs. the peer group average at 5.0x EV/Revenue multiple of CY20 estimates,” he notes.

And while some investors may be spotting a trend of softness from VPY, Rosenberg says better things are bubbling beneath the surface.

“Following a few soft growth quarters, VersaPay is now showing signs of improvement with a strong backlog, ARR growth and new customer wins,” he writes. “We maintain our target price of $2.30 and believe VersaPay offers an attractive return to investors at these levels.”

Tagged with: vpy
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Has Canadian unemployment peaked?

Canada’s labour market has softened sharply since the start of the year, with the unemployment rate reaching 7% in May,… [Read More]

2 days ago

MDA wins huge price target raise at RBC

Count RBC Capital Markets analyst Ken Herbert among the believers in MDA (MDA Stock Quote, Chart, News, Analysts, Financials TSX:MDA).… [Read More]

2 days ago

Netlist stock is a buy, Roth says

Roth Capital Markets analyst Suji Desilva said in a July 3 report that Netlist (Netlist Stock Quote, Chart, News, Analysts,… [Read More]

2 days ago

Theratechnologies shareholders should take the deal, Research Capital says

Research Capital analyst Andre Uddin is recommending Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:THTX) shareholders tender their shares… [Read More]

2 days ago

Haywood raises price target on KITS Eyecare to $21.00

Haywood Capital Markets analyst Gianluca Tucci reiterated a “Buy” rating on KITS Eyecare (KITS Eyecare Stock Quote, Chart, News, Analysts,… [Read More]

3 days ago

QBTS stock is still undervalued, this analyst says

Roth Capital Markets analyst Suji Desilva maintained a “Buy” rating and US$18.00 target on D-Wave Quantum (D-Wave Quantum Stock Quote,… [Read More]

3 days ago